Tag

• UGI USER
• drug access government healthcare healthcare policy India TB control off-patent drugs pharma regulation public health policy TB drugs TB medicine distribution tuberculosis treatment
• 66
• 0

TB Drugs Off-Patent: Govt Channels Only Access

OFF-PATENT TB DRUGS RESTRICTED TO GOVT CHANNELS Why in the News? DCGI directive: India will restrict off-patent TB drugs like Bedaquiline and Delamanid to government supply chains Policy aim: The move aligns with the National TB Elimination Programme (NTEP) to prevent drug resistance. Regulatory order: All packaging must now carry the warning: “For use in …

Read More